Alert FDA OKs Neuromodulation Device to Improve Gait in MS The Portable Neuromodulation Stimulator (PoNS) is intended for use in combination with a supervised therapeutic exercise program in patients ...
VARC-3 Sets Goalpost for Future Aortic Valve Trials The new definitions and endpoints have gotten pushback from surgeons who say they will tip the balance in favor of transcatheter approaches.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback